Advertisement

Topics

Mylan, like other generic drugmakers, feels the pricing pain

09:50 EDT 9 Aug 2017 | STAT

Mylan's second-quarter profit surged, but not as much as Wall Street had expected and the company is taking a more conservative view going forward.

Original Article: Mylan, like other generic drugmakers, feels the pricing pain

NEXT ARTICLE

More From BioPortfolio on "Mylan, like other generic drugmakers, feels the pricing pain"

Quick Search
Advertisement